Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all
Page 1
Call to action: how can the US Ending the HIV Epidemic initiative succeed?
Beyrer C, Adimora AA, Hodder SL, Hopkins E, Millett G, Mon SHH, Sullivan PS, Walensky RP, Pozniak A, Warren M, Richman B, Copeland R, Mayer KH. Beyrer C, et al. Lancet. 2021 Feb 18:S0140-6736(21)00390-1. doi: 10.1016/S0140-6736(21)00390-1. Online ahead of print. Lancet. 2021. PMID: 33617770 Review.
In this watershed year of 2021 and in the face of the COVID-19 pandemic, it is clear that the USA will not meet the stated goals of the National HIV/AIDS Strategy, particularly those goals relating to reductions in new infections, decreases in morbidity, and reductions in HIV sti …
In this watershed year of 2021 and in the face of the COVID-19 pandemic, it is clear that the USA will not meet the stated goals of the Nati …
The opioid crisis and HIV in the USA: deadly synergies.
Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, Beyrer C. Hodder SL, et al. Lancet. 2021 Feb 18:S0140-6736(21)00391-3. doi: 10.1016/S0140-6736(21)00391-3. Online ahead of print. Lancet. 2021. PMID: 33617769 Review.
HIV and women in the USA: what we know and where to go from here.
Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D, Auerbach JD, Agwu AL, Currier J, Gandhi M. Adimora AA, et al. Lancet. 2021 Feb 18:S0140-6736(21)00396-2. doi: 10.1016/S0140-6736(21)00396-2. Online ahead of print. Lancet. 2021. PMID: 33617768 Review.
Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.
Sullivan PS, Satcher Johnson A, Pembleton ES, Stephenson R, Justice AC, Althoff KN, Bradley H, Castel AD, Oster AM, Rosenberg ES, Mayer KH, Beyrer C. Sullivan PS, et al. Lancet. 2021 Feb 18:S0140-6736(21)00395-0. doi: 10.1016/S0140-6736(21)00395-0. Online ahead of print. Lancet. 2021. PMID: 33617774 Review.
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Clutterbuck EA, Collins AM, Cutland CL, Darton TC, Dheda K, Dold C, Duncan CJA, Emary KRW, Ewer KJ, Flaxman A, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Galiza E, Goodman AL, Green CM, Green CA, Greenland M, Hill C, Hill HC, Hirsch I, Izu A, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Libri V, Lillie PJ, Marchevsky NG, Marshall RP, Mendes AVA, Milan EP, Minassian AM, McGregor A, Mujadidi YF, Nana A, Padayachee SD, Phillips DJ, Pittella A, Plested E, Pollock KM, Ramasamy MN, Ritchie AJ, Robinson H, Schwarzbold AV, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Thomson EC, Török ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, White T, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ; Oxford COVID Vaccine Trial Group. Voysey M, et al. Lancet. 2021 Feb 19;397(10277):881-91. doi: 10.1016/S0140-6736(21)00432-3. Online ahead of print. Lancet. 2021. PMID: 33617777 Free PMC article.
Myanmar's health leaders stand against military rule.
Soe ZW, Oo MM, Wah KS, Naing AT, Skalicky-Klein R, Phillips G. Soe ZW, et al. Lancet. 2021 Feb 19:S0140-6736(21)00457-8. doi: 10.1016/S0140-6736(21)00457-8. Online ahead of print. Lancet. 2021. PMID: 33617775 No abstract available.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page